These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15248031)

  • 21. Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations.
    Velickovic M; Velickovic Z; Dunckley H
    Immunogenetics; 2006 Jul; 58(7):523-32. PubMed ID: 16733717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
    Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role genes encoding of killer cell immunoglobulin-like receptors (KIRs) and their ligands in susceptibility to and progression of HIV infection.
    Błachowicz O; Zwolińska K
    Postepy Hig Med Dosw (Online); 2016 Dec; 70(0):1409-1423. PubMed ID: 28100849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands.
    Jennes W; Verheyden S; Demanet C; Adjé-Touré CA; Vuylsteke B; Nkengasong JN; Kestens L
    J Immunol; 2006 Nov; 177(10):6588-92. PubMed ID: 17082569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.
    Jones DC; Edgar RS; Ahmad T; Cummings JR; Jewell DP; Trowsdale J; Young NT
    Genes Immun; 2006 Oct; 7(7):576-82. PubMed ID: 16929347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
    Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
    Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
    Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased interferon-γ production by NK cells from KIR haplotype B carriers in hepatitis C virus infection.
    Mele D; Pasi A; Cacciatore R; Mantovani S; Oliviero B; Mondelli MU; Varchetta S
    Liver Int; 2019 Jul; 39(7):1237-1245. PubMed ID: 31177636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.
    Akhtari M; Farazmand A; Mahmoudi M; Akbarian M; Ahmadzadeh N; Mirkazemi Z; Mostafaei S; Jamshidi AR
    Lupus; 2016 Oct; 25(11):1244-53. PubMed ID: 26989167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.
    Martin MP; Nelson G; Lee JH; Pellett F; Gao X; Wade J; Wilson MJ; Trowsdale J; Gladman D; Carrington M
    J Immunol; 2002 Sep; 169(6):2818-22. PubMed ID: 12218090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.
    Ashouri E; Rajalingam K; Barani S; Farjadian S; Ghaderi A; Rajalingam R
    Sci Rep; 2021 Apr; 11(1):7932. PubMed ID: 33846431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.
    Naumova E; Mihaylova A; Ivanova M; Mihailova S
    Cancer Immunol Immunother; 2007 Jan; 56(1):95-100. PubMed ID: 16547704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
    Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
    J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis.
    Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Asadifar B
    Iran J Immunol; 2010 Jun; 7(2):88-95. PubMed ID: 20574122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of KIR and CD16A genotypes in colorectal carcinoma genetic risk and clinical stage.
    Canossi A; Aureli A; Del Beato T; Rossi P; Franceschilli L; De Sanctis F; Sileri P; di Lorenzo N; Buonomo O; Lauro D; Venditti A; Sconocchia G
    J Transl Med; 2016 Aug; 14(1):239. PubMed ID: 27519478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
    Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
    Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
    Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of incompatible killer cell immunoglobulin-like receptor and its ligand on the outcome of haploidentical bone marrow transplantation.
    Duan LN; Han HX; Liu J; Yan HM; Zhu L; Xue M; Ding L; Zhu PY; Wang HX; Ji SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):809-15. PubMed ID: 17708809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.